Literature DB >> 1383973

Neurocardiac responses to vagoafferent electrostimulation in humans.

M V Kamath1, A R Upton, A Talalla, E L Fallen.   

Abstract

UNLABELLED: To determine if cardiac vagal tone is enhanced by vagal electrostimulation (VES), we examined the heart rate autospectrum (HRA) in eight patients with implanted stimulators for complex partial seizures. In four patients the VES was activated at 30 Hz and 500-msec pulse (HiStim group) compared to 2 Hz and 130-msec pulse for the LoStim group (n = 4). Continuous ECG and respiratory waveforms were recorded for 45 minutes every 8 hours (7-8 AM; 3-4 PM 11-12 PM) during resting supine wakeful epochs both before and 15 days after surgical implantation. From the HRA cardiac sympathovagal balance was expressed as the ratio of the low frequency (LF) power to the high frequency (HF) power.
RESULTS: There were no presurgical differences between the groups in heart rate, its variance, or the energies contained in any autospectral band. The LoStim group showed no significant change in heart rate (HR), HF peak power, or LF:HF ratios during 2 weeks of VES. Conversely, in the HiStim group, the LF:HF peak power ratio (an expression of sympathetic dominance) decreased from 2.5 +/- 1.5 preimplant to 1.5 +/- 0.49 (P < 0.02) with VES. During VES there was a significantly higher HF power in the HiStim compared to LoStim group. No diurnal variations in HRA values were seen for either group.
CONCLUSIONS: (1) A relationship exists between selective vagal nerve electrostimulation and the HRA; and (2) high stimulation frequency of the vagus nerve in man is associated with sustained augmentation of cardiac vagal tone throughout a 24-hour cycle.

Entities:  

Mesh:

Year:  1992        PMID: 1383973     DOI: 10.1111/j.1540-8159.1992.tb02937.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  9 in total

1.  The effect of sham feeding on neurocardiac regulation in healthy human volunteers.

Authors:  M V Kamath; R Spaziani; S Ullal; G Tougas; J C Guzman; C Morillo; J Capogna; Mohammed Al-Bayati; David Armstrong
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

Review 2.  Vagal afferent stimulation as a cardioprotective strategy? Introducing the concept.

Authors:  Ernest L Fallen
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

Review 3.  Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans.

Authors:  Jani Penttilä; Tom Kuusela; Harry Scheinin
Journal:  Eur J Clin Pharmacol       Date:  2005-08-30       Impact factor: 2.953

4.  Circadian periodicity of heart rate variability in hospitalized angor patients.

Authors:  Carlos E D'Negri; Liliana Marelich; Daniel Vigo; Rafael S Acunzo; Luis A Girotti; Daniel P Cardinali; Leonardo Nicola Siri
Journal:  Clin Auton Res       Date:  2005-06       Impact factor: 4.435

Review 5.  "The Wandering Nerve Linking Heart and Mind" - The Complementary Role of Transcutaneous Vagus Nerve Stimulation in Modulating Neuro-Cardiovascular and Cognitive Performance.

Authors:  Helena Dolphin; Tim Dukelow; Ciaran Finucane; Sean Commins; Paul McElwaine; Sean P Kennelly
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

6.  Cardiac autonomic function and oesophageal acid sensitivity in patients with non-cardiac chest pain.

Authors:  G Tougas; R Spaziani; S Hollerbach; V Djuric; C Pang; A R Upton; E L Fallen; M V Kamath
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

7.  Left-sided vagus nerve stimulation decreases intracranial pressure without resultant bradycardia in the pig: a potential therapeutic modality for humans.

Authors:  R Shane Tubbs; John C Wellons; Jeffrey P Blount; W Jerry Oakes
Journal:  Childs Nerv Syst       Date:  2004-04-09       Impact factor: 1.475

Review 8.  Cardiovascular autonomic effects of vagus nerve stimulation.

Authors:  Iñigo Garamendi-Ruiz; Juan Carlos Gómez-Esteban
Journal:  Clin Auton Res       Date:  2017-10-25       Impact factor: 4.435

9.  Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.

Authors:  G Venkatesh; E L Fallen; M V Kamath; S Connolly; S Yusuf
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.